Elevai Labs, Inc. Common Stock (ELAB)

USD 2.15

(9.14%)

Market Cap (In USD)

6.6 Million

Revenue (In USD)

1.71 Million

Net Income (In USD)

-4.3 Million

Avg. Volume

3.66 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.74-778.0
PE
-
EPS
-
Beta Value
0.0
ISIN
US28622K1043
CUSIP
-
CIK
1840563
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Graydon Bensler C.F.A.
Employee Count
-
Website
-
Ipo Date
Details
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

More Stocks